Cerevast Therapeutics Obtains $10,000,000 New Financing Round

  • Feed Type
  • Date
    12/30/2014
  • Company Name
    Cerevast Therapeutics
  • Mailing Address
    12277 134th Court NE Redmond, WA 98052 USA
  • Company Description
    Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders.
  • Website
    http://www.cerevast.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy